Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

A new nationwide Danish study published in The Lancet Psychiatry found that individuals with schizophrenia spectrum disorders ...

When states legalize medical and recreational cannabis, fewer prescriptions for anxiety are filled, but more for depression ...

The following research questions were investigated: How much cognitive impairment do antipsychotic drug-naive FEP patients ...

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

Although it might be an interesting study, there aren’t any randomized, controlled trials of antipsychotic medications for ...

Providing the latest peer-reviewed research on the clinical and biological aspects of treating this patient population with psychotropic medications, including side effects and interactions ...

The following is a summary of “Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders ...

The following section will detail notable types of BZDs and the drugs that comprise these categories, including potential side effects. Antipsychotic medications are prescription pharmaceuticals used ...

There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...

There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...